Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 12/20 | 0.51 |
| ▸ | PPARG | P37231 | 4/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.42 |
| ▸ | PRKCG | P05129 | 2/20 | 0.42 |
| ▸ | PRKCB | P05771 | 2/20 | 0.42 |
| ▸ | PRKCH | P24723 | 2/20 | 0.42 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.42 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.42 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.42 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.42 |
| ▸ | ABHD16A | O95870 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20057474 | 1.00 | PRKCA (0.51) | PRKCAPPARGTYRPRKD3PRKCG | |
| SCHEMBL666234 | 1.00 | PRKCA (0.51) | PRKCAPPARGTYRPRKD3PRKCG | |
| SCHEMBL665964 | 1.00 | PRKCA (0.51) | PRKCAPPARGTYRPRKD3PRKCG | |
| SCHEMBL663160 | 1.00 | PRKCA (0.51) | PRKCAPPARGTYRPRKD3PRKCG | |
| SCHEMBL10186551 | 1.00 | PRKCA (0.51) | PRKCAPPARGTYRPRKD3PRKCG | |
| SCHEMBL10186552 | 1.00 | PRKCA (0.51) | PRKCAPPARGTYRPRKD3PRKCG | |
| SCHEMBL664841 | 1.00 | PRKCA (0.51) | PRKCAPPARGTYRPRKD3PRKCG | |
| SCHEMBL10186550 | 1.00 | PRKCA (0.51) | PRKCAPPARGTYRPRKD3PRKCG | |
| SCHEMBL21182172 | 1.00 | PRKCA (0.51) | PRKCAPPARGTYRPRKD3PRKCG | |
| SCHEMBL6531941 | 1.00 | PRKCA (0.51) | PRKCAPPARGTYRPRKD3PRKCG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3543310-B2 | COMPOSITIONS COMPRISING HFC-1234YF AND HFC-32 | CHEMOURS CO FC LLC (US) | 2024-07-03 | — | — | EP | disclosed |
| US-20220389297-A1 | COMPOSITIONS COMPRISING A FLUOROOLEFIN | THE CHEMOURS COMPANY FC, LLC (US) | 2022-12-08 | — | — | US | disclosed |
| US-11124685-B2 | Compositions comprising fluoroolefins and uses thereof | THE CHEMOURS COMPANY FC, LLC (US) | 2021-09-21 | — | — | US | disclosed |
| US-20210207014-A1 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | THE CHEMOURS COMPANY FC, LLC (US) | 2021-07-08 | — | — | US | disclosed |
| US-11046876-B2 | Compositions comprising fluoroolefins and uses thereof | THE CHEMOURS COMPANY FC, LLC (US) | 2021-06-29 | — | — | US | disclosed |
| US-11046875-B2 | Compositions comprising a fluoroolefin | THE CHEMOURS COMPANY FC, LLC (US) | 2021-06-29 | — | — | US | disclosed |
| US-11046877-B1 | Compositions comprising fluoroolefins and uses thereof | THE CHEMOURS COMPANY FC, LLC (US) | 2021-06-29 | — | — | US | disclosed |
| US-11034872-B2 | Compositions comprising a fluoroolefin | THE CHEMOURS COMPANY FC, LLC (US) | 2021-06-15 | — | — | US | disclosed |
| EP-3461871-B1 | COMPOSITIONS COMPRISING TRANS HFC-1234ZE AND HFC-1234YF | CHEMOURS CO FC LLC (US) | 2021-01-20 | — | — | EP | disclosed |
| US-10883030-B2 | Compositions comprising a fluoroolefin | THE CHEMOURS COMPANY FC, LLC (US) | 2021-01-05 | — | — | US | disclosed |
| WO-2007053697-A2 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-05-10 | — | — | WO | disclosed |
| US-7208100-B2 | 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane refrigerant compositions comprising a fluoroether and uses thereof | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-04-24 | — | — | US | disclosed |
| US-7208099-B2 | Refrigerant compositions comprising 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane and a hydrofluorocarbon and uses thereof | E. I. DU PONT DE NEMOURS & COMPANY (US) | 2007-04-24 | — | — | US | disclosed |
| US-7157020-B2 | Refrigerant compositions comprising performance enhancing additives | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-01-02 | — | — | US | disclosed |
| US-5416224-A | Reaction of acetyldihydro-2-(3H)-furanone with aldehyde and alkali metal hydroxide | HENKEL CORPORATION (US) | 1995-05-16 | — | — | US | disclosed |
| EP-0559789-A1 | PROCESS FOR THE PREPARATION OF $g(a)-ALKYL LACTONES | HENKEL CORPORATION (US) | 1993-09-15 | — | — | EP | disclosed |
| US-5231192-A | Reacting an a-acyl lactone, an aldehyde and an alkali metal hydroxide; hydrogenation | HENKEL CORPORATION (US) | 1993-07-27 | — | — | US | disclosed |
| WO-1992010487-A1 | PROCESS FOR CONVERTING α-ACYL-SUBSTITUTED LACTONES TO α-ALKYLIDENE-SUBSTITUTED LACTONES | HENKEL CORPORATION (US) | 1992-06-25 | — | — | WO | disclosed |
| WO-1992009590-A1 | PROCESS FOR THE PREPARATION OF α-ALKYL LACTONES | HENKEL CORPORATION (US) | 1992-06-11 | — | — | WO | disclosed |
| US-4980342-A | Process for the preparation of α-alkyl lactones | HENKEL CORPORATION (US) | 1990-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11046876-B2 | Compositions comprising fluoroolefins and uses thereof | GFPT1, PFAS, TRMT1 | PRKCA 4469/4885PPARG 2047/4885TYR 1155/4885 |
| US-11046877-B1 | Compositions comprising fluoroolefins and uses thereof | GFPT1, PFAS, TRMT1 | PRKCA 4469/4885PPARG 2047/4885TYR 1155/4885 |
| US-20210207014-A1 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | GFPT1, PFAS, TRMT1 | PRKCA 4469/4885PPARG 2047/4885TYR 1155/4885 |
| US-11124685-B2 | Compositions comprising fluoroolefins and uses thereof | GFPT1, PFAS, TRMT1 | PRKCA 4469/4885PPARG 2047/4885TYR 1155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.